New and unusual scaffolds in medicinal chemistry

被引:328
作者
Marson, Charles M. [1 ]
机构
[1] UCL, Dept Chem, Christopher Ingold Labs, London WC1H 0AJ, England
关键词
BIOLOGICAL EVALUATION; IN-VIVO; RECEPTOR ANTAGONISTS; BINDING-AFFINITY; DRUG DISCOVERY; HIGHLY POTENT; INHIBITORS; DESIGN; DERIVATIVES; SERIES;
D O I
10.1039/c1cs15119c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Contemporary medicinal chemistry faces diverse challenges from several directions, including the need for both potency and specificity of any therapeutic agent; the increasingly demanding requirements of low toxicity shown across all patients treated; and the need for novelty in intellectual property, given the extensive use of benzenoid and heteroaromatic ring systems in numerous patents. Increasingly, such challenges are being met by a shift to new and/or unusual ring systems (scaffolds) that lie outside the field of (hetero)aromatic systems. This critical review surveys a necessarily limited selection of currently atypical scaffolds, chiefly drawn from the literature of the last three years, that have found application in medicinal chemistry, some being present in agents with therapeutic potential while others are found in agents already in clinical use (163 references).
引用
收藏
页码:5514 / 5533
页数:20
相关论文
共 162 条
  • [1] ADORJAN I, 2009, Patent No. 2009076693
  • [2] Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents
    Ahmad, Saleem
    Ngu, Khehyong
    Miller, Keith J.
    Wu, Ginger
    Hung, Chen-pin
    Malmstrom, Sarah
    Zhang, Ge
    O'Tanyi, Eva
    Keim, William J.
    Cullen, Mary Jane
    Rohrbach, Kenneth W.
    Thomas, Michael
    Ung, Thao
    Qu, Qinling
    Gan, Jinping
    Narayanan, Rangaraj
    Pelleymounter, Mary Ann
    Robl, Jeffrey A.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1128 - 1133
  • [3] AISSAOUI H, 2009, Patent No. 2009004584
  • [4] Aissaoui H., 2009, [No title captured], Patent No. [WO/2009/016560 A2, 2009016560, WO 2009016560A2]
  • [5] AISSAOUI H, 2009, Patent No. 2009016564
  • [6] Total synthesis and biological evaluation of tambjamine K and a library of unnatural analogs
    Aldrich, Leslie N.
    Stoops, Sydney L.
    Crews, Brenda C.
    Marnett, Lawrence J.
    Lindsley, Craig W.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) : 5207 - 5211
  • [7] ARORA S, 2010, Patent No. 20100291020
  • [8] Synthesis of novel β-lactam fused spiroisoxazolidine chromanones and tetralones as potent antimicrobial agent for human and plant pathogens
    Arumugam, Natarajan
    Raghunathan, Raghavachary
    Shanmugaiah, Vellaisamy
    Mathivanan, Narayanasamy
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3698 - 3702
  • [9] Banka A., 2010, Patent Application WO, Patent No. [2010/091411-A1, 2010091411]
  • [10] Tetrahydroindolizinone NK1 antagonists
    Bao, Jianming
    Lu, Huagang
    Morriello, Gregori J.
    Carlson, Emma J.
    Wheeldon, Alan
    Chicchi, Gary G.
    Kurtz, Marc M.
    Tsao, Kwei-Lan C.
    Zheng, Song
    Tong, Xinchun
    Mills, Sander G.
    DeVita, Robert J.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2354 - 2358